omega-n-methylarginine has been researched along with Heart Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkinson, G; Aziz, NF; Cable, NT; Cuthbertson, DJ; Daousi, C; Green, DJ; Jones, H; Kemp, GJ; Pugh, CJ; Sprung, VS | 1 |
Banks, SM; Correa, R; Danner, RL; Eichacker, PQ; Ferantz, V; Gerstenberger, E; Natanson, C; Sevransky, J; Vandivier, RW | 1 |
Davies, CH; Harding, SE; Money-Kyrle, AM; Poole-Wilson, PA | 1 |
Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
1 trial(s) available for omega-n-methylarginine and Heart Diseases
Article | Year |
---|---|
Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.
Topics: Adult; Case-Control Studies; Enzyme Inhibitors; Exercise; Exercise Therapy; Female; Heart Diseases; Heart Function Tests; Hot Temperature; Humans; Insulin Resistance; Laser-Doppler Flowmetry; Lipoproteins, LDL; Microdialysis; Microvessels; Nitric Oxide; omega-N-Methylarginine; Polycystic Ovary Syndrome; Regional Blood Flow; Skin; Vasodilation | 2013 |
4 other study(ies) available for omega-n-methylarginine and Heart Diseases
Article | Year |
---|---|
Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs.
Topics: Animals; Blood Pressure; Dogs; Enzyme Inhibitors; Heart Diseases; Heart Rate; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Stroke Volume; Tumor Necrosis Factor-alpha; Vascular Resistance; Ventricular Function, Left | 2005 |
An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
Topics: Adrenergic beta-Agonists; Adult; Aged; Analysis of Variance; Cell Size; Cells, Cultured; Child; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart Diseases; Humans; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Receptors, Adrenergic, beta | 1998 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
Impaired exercise-induced vasodilatation in chronic atrial fibrillation--role of endothelium-derived nitric oxide.
Topics: Acetylcholine; Adult; Aged; Atrial Fibrillation; Blood Flow Velocity; Chronic Disease; Electric Countershock; Endothelium, Vascular; Female; Forearm; Hand Strength; Heart Diseases; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Vasodilation | 2002 |